Осмолярность мочи (оценка концентрационной способности почек)\Osmolality of Urine

The Renal Function Panel (laboratory evaluation of kidney function) is used to assess glomerular filtration, tubular handling of solutes, and overall renal homeostasis in acute and chronic kidney disorders. It supports diagnosis of conditions such as glomerulonephritis, pyelonephritis, interstitial nephritis, amyloidosis, and acute or chronic kidney failure, and aids in the differential diagnosis of urinary tract disease. It also serves to evaluate renal involvement in systemic illnesses—including diabetes mellitus, hypertension, systemic lupus erythematosus, amyloidosis, vasculitis, and plasma cell myeloma—as well as traumatic renal injury. The panel is used to monitor chronic kidney disease and renal insufficiency, follow patients receiving dialysis, assess graft function after kidney transplantation, and track response to therapy for renal pathology.

The kidneys filter blood to remove metabolic waste, generate urine, and maintain fluid, electrolyte, and acid–base balance. They produce renin, which participates in blood pressure regulation, and erythropoietin, which stimulates erythropoiesis. Renal function is influenced by antidiuretic hormone, aldosterone, and cortisol, and the kidneys contribute to calcium–phosphate homeostasis under the actions of parathyroid hormone and vitamin D. Kidney disease leads to retention of toxins and fluid and disturbances in osmotic balance; advanced disease may require hemodialysis or renal transplantation. More than 100 conditions can impair renal function. Common etiologies include diabetes mellitus, hypertension, infections, autoimmune diseases (eg, systemic lupus erythematosus, vasculitides), neoplasms, congenital anomalies of the urinary tract, and mineral metabolism disorders. Early decline in function is often silent. Suggestive manifestations include periorbital and dependent edema (ankles, legs, chest, abdomen), changes in urine color, clarity, or volume, increased urination (particularly at night), and flank pain. With progression, patients may develop pruritus, anorexia, nausea, vomiting, edema with paresthesias of the extremities, marked fatigue, reduced concentration, skin darkening, and seizures. Laboratory abnormalities typically precede overt symptoms. Several clinico‑laboratory patterns help localize pathophysiology. Impaired excretory function presents with elevated blood urea, metabolic acidosis, and altered electrolyte ratios. Defects in concentrating or diluting ability are reflected by changes in urine specific gravity and its diurnal profile. Reabsorptive defects cause excessive water loss and renal wasting of sodium, potassium, phosphates, and bicarbonate. Secretory defects—often genetic—lead to phosphaturia, bicarbonaturia, and renal tubular acidosis. Vascular injury from hypertension, atherosclerosis, or diabetes reduces filtration capacity. Glomerular injury due to autoimmune disease or poststreptococcal processes disrupts filtration and increases urinary loss of proteins, glucose, and formed elements; glomerulonephritis characteristically produces hematuria, leukocyturia, proteinuria, and disturbances in serum electrolytes. Nephrotic syndrome denotes heavy proteinuria with edema. Infection may reach the kidneys hematogenously or ascend from the bladder in the setting of cystitis, causing pyelonephritis or tubulointerstitial nephritis. Laboratory findings include evidence of acute inflammation with leukocytosis in blood and urine and bacteriuria. Chronic glomerulonephritis or pyelonephritis can progress to chronic kidney disease and renal failure, with increased serum creatinine, urea, and potassium, augmented urinary loss of sodium and protein, dysregulation of blood pressure and erythropoiesis, and anemia. Obstructive processes—such as urolithiasis, tumors, ureteral compression during pregnancy, or prostatic enlargement—produce elevations in creatinine and urea and electrolyte disturbances that affect other organ systems. Identification of acute or chronic renal failure warrants prompt management to limit progression. Comprehensive evaluation integrates clinical assessment, laboratory testing, imaging (renal ultrasound or CT), and, in selected cases, kidney biopsy.